We previously reported that high CHAF1A expression is associated with high‐risk disease and poor clinical outcome in NB.[26] Here, we demonstrate that CHAF1A promotes NB cell malignancy and oncogenesis by restricting neuronal differentiation and reprogramming cell metabolism. Here, CHAF1A is linked to neuroblastoma.